1,4-benzothiazine analogues and apoptosis: structure-activity relationship.

[1]  C. Riccardi,et al.  Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. , 2003, Blood.

[2]  F. Bistoni,et al.  Anti-Candida albicans properties of novel benzoxazine analogues. , 2002, Bioorganic & medicinal chemistry.

[3]  C. Riccardi,et al.  Induction of apoptosis by 1,4-benzothiazine analogs in mouse thymocytes. , 2002, The Journal of pharmacology and experimental therapeutics.

[4]  P. Krammer,et al.  CD95's deadly mission in the immune system , 2000, Nature.

[5]  K. Okuyama,et al.  T-477, a novel Ca(2+)- and Na(+) channel blocker, prevents veratridine-induced neuronal injury. , 2000, European journal of pharmacology.

[6]  N. Sakato,et al.  Thymocyte Apoptosis by T-2 Toxin in Vivo in Mice Is Independent of Fas/Fas Ligand System , 2000, Bioscience, biotechnology, and biochemistry.

[7]  C. Riccardi,et al.  Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. , 1999, Blood.

[8]  K. Wakamatsu,et al.  Comparison of antimelanoma effects of 4‐S‐cysteaminylphenol and its homologues , 1998, Melanoma research.

[9]  G. Dryhurst,et al.  Irreversible Inhibition of Mitochondrial Complex I by 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1): A Putative Nigral Endotoxin of Relevance to Parkinson's Disease , 1997, Journal of neurochemistry.

[10]  Y. Mori,et al.  Inhibitory effects of a new neuroprotective diltiazem analogue, T-477, on cloned brain Ca2+ channels expressed in Xenopus oocytes. , 1997, European journal of pharmacology.

[11]  K. Wakamatsu,et al.  Dihydro-1,4-benzothiazine-6,7-dione, the ultimate toxic metabolite of 4-S-cysteaminylphenol and 4-S-cysteaminylcatechol. , 1997, Biochemical pharmacology.

[12]  G. Dryhurst,et al.  Oxidation of dopamine in the presence of cysteine: characterization of new toxic products. , 1997, Chemical research in toxicology.

[13]  G. Dryhurst,et al.  Further insights into the influence of L-cysteine on the oxidation chemistry of dopamine: reaction pathways of potential relevance to Parkinson's disease. , 1996, Chemical research in toxicology.

[14]  G. Dryhurst,et al.  Oxidation chemistry of (-)-norepinephrine in the presence of L-cysteine. , 1996, Journal of medicinal chemistry.

[15]  V. Wahn,et al.  Nitric oxide induces apoptosis in mouse thymocytes. , 1995, Journal of immunology.

[16]  L. Zwelling,et al.  Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7 H- pyridol[1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161). , 1995, Biochemical pharmacology.

[17]  Seamus J. Martin,et al.  Proteolysis of Fodrin (Non-erythroid Spectrin) during Apoptosis (*) , 1995, The Journal of Biological Chemistry.

[18]  T. Tadakuma,et al.  Modulation of thymocyte apoptosis by isoproterenol and prostaglandin E2. , 1991, Cellular immunology.

[19]  S. Orrenius,et al.  Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. , 1990, Journal of immunology.

[20]  S. Enna.  On-Line Submission and Review , 2002 .

[21]  H. Diehl,et al.  Cholesterol induced variations of membrane dynamics related to the induction of apoptosis in mouse thymocytes. , 1998, International journal of radiation biology.